INTEGRA Biosciences’ pipettes are endorsed by ergonomics champion iHEALTH 360

Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. Georgia Abortion Ban Linked to Two

Celcuity is planning a Phase Ib/II trial for its prostate cancer therapy. Credit: FatCamera via Getty Images. US-based Celcuity has announced a new clinical trial

Share this article The immunology portfolio of AbbVie, which faced stiff competition from Humira biosimilars, saw revenues decrease by 9.6% to $26.14bn. Credit: Valery Zankovych